bioRxiv · 10.1101/2020.07.16.206870
ShcA promotes chondrocyte hypertrophic commitment and osteoarthritis in mice through RunX2 nuclear translocation and YAP1 inactivation
Abstract
Chondrocyte hypertrophic differentiation, a key process in endochondral ossification (EO), is also a feature of osteoarthritis leading to articular cartilage destruction. ShcA (Src homology and Collagen A) is an adaptor protein that binds to the cytoplasmic tail of receptor tyrosine kinases. We found that deletion of ShcA in chondrocytes of mice inhibits hypertrophic differentiation, alters the EO process, and leads to dwarfism. ShcA promotes ERK1/2 activation, nuclear translocation of the master transcription factor for chondrocyte hypertrophy, RunX2, while maintaining the Runx2 inhibitor YAP1 in its cytosolic inactive form. This leads to hypertrophic commitment and expression of markers of hypertrophy, such as Collagen X. In addition, ShcA deletion in chondrocytes protects from age-related osteoarthritis development in mice. Our results reveal that ShcA integrates multiple stimuli which affect the intracellular signaling processes leading to the hypertrophic commitment of chondrocytes and osteoarthritis.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Abou-Jaoude, A., Courtes, M., Badique, L., Elhaj Mahmoud, D., Abboud, C., Mlih, M., Justiniano, H., Lemle, A., Awan, S., Terrand, J., Niemeier, A., Barbero, A., Houard, X., Boucher, P., Matz, R. L.. 2020-07-17. ShcA promotes chondrocyte hypertrophic commitment and osteoarthritis in mice through RunX2 nuclear translocation and YAP1 inactivation. https://doi.org/10.1101/2020.07.16.206870
Cite the original work for its findings. Save a collection to share your selection of sources.